sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation
- 31 December 2006
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 17 (1), 70-73
- https://doi.org/10.1016/j.trim.2006.09.009
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Soluble HLA-G Expression and Renal Graft AcceptanceAmerican Journal of Transplantation, 2006
- Immuno-tolerogenic functions of HLA-G: Relevance in transplantation and oncologyAutoimmunity Reviews, 2005
- Tolerization of dendritic cells by HLA‐GEuropean Journal of Immunology, 2005
- Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA‐G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patientsEuropean Journal of Immunology, 2004
- Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver–kidney transplantation: possible implications for monitoring patientsHuman Immunology, 2003
- Biology and functions of human leukocyte antigen‐G in health and sickness*Tissue Antigens, 2003
- Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-GProceedings of the National Academy of Sciences, 2003
- Implication of HLA-G molecule in heart-graft acceptanceThe Lancet, 2000
- The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cellsEuropean Journal of Immunology, 1999
- Structure and function of the human MHC class Ib molecules HLA‐E, HLA‐F and HLA‐GImmunological Reviews, 1998